Using FAVS, we demonstrated that sEVs double-positive for DPEP1 and CEA were much higher in the plasma from patients with CRC compared with the controls, suggesting that DPEP1 may be a promising biomarker and target for a subset of patients with CRC (Fig. 7g and Extended Data Fig. 7g). Here, CEACAM5 is linked to colorectal carcinoma.